Meridian Bioscience, Inc. (VIVO) Reports Third Quarter and Nine Months Operating Results, Declares Regular Cash Dividend, and Reaffirms Fiscal 2013 Guidance
7/25/2013 7:55:26 AM
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ: VIVO) today:
•reported fiscal 2013 third quarter and nine months net sales of $47.1 million and $139.7 million, respectively, increases of 12% and 8%, respectively, from the same periods of the prior fiscal year;
•reported third quarter operating income of $15.7 million, an increase of 24% over the same period of the prior fiscal year;
Help employers find you! Check out all the jobs and post your resume.
comments powered by